Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation.

Abstract:

:Cbl-b, a mammalian homolog of Cbl, consists of an N-terminal region (Cbl-b-N) highly homologous to oncogenic v-Cbl, a Ring finger, and a C-terminal region containing multiple proline-rich stretches and potential tyrosine phosphorylation sites. In the present study, we demonstrate that upon engagement of the T cell receptor (TCR), endogenous Cbl-b becomes rapidly tyrosine-phosphorylated. In heterogeneous COS-1 cells, Cbl-b was phosphorylated on tyrosine residues by both Syk- (Syk/Zap-70) and Src- (Fyn/Lck) family kinases, with Syk kinase inducing the most prominent effect. Syk associates and phosphorylates Cbl-b in Jurkat T cells. A Tyr-316 Cbl-binding site in Syk was required for the association with and for the maximal tyrosine phosphorylation of Cbl-b. Mutation at a loss-of-function site (Gly-298) in Cbl-b-N disrupts its interaction with Syk. Cbl-b constitutively binds Grb2 and becomes associated with Crk-L upon TCR stimulation. The Grb2- and the Crk-L-binding regions were mapped to the C-terminus of Cbl-b. The Crk-L-binding sites were further determined to be Y655DVP and Y709KIP, with the latter being the primary binding site. Taken together, these results implicate that Cbl-b is involved in TCR-mediated intracellular signaling pathways.

journal_name

Oncogene

journal_title

Oncogene

authors

Elly C,Witte S,Zhang Z,Rosnet O,Lipkowitz S,Altman A,Liu YC

doi

10.1038/sj.onc.1202411

subject

Has Abstract

pub_date

1999-02-04 00:00:00

pages

1147-56

issue

5

eissn

0950-9232

issn

1476-5594

journal_volume

18

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

    abstract::Resistance to TGF-beta1 occurred in pancreatic cancer cells suggesting that inactivation of TGF-beta inhibitory signaling pathways may play an important role in human pancreatic cancer. The aim of our study was to determine the presence of alterations in the main putative components of the TGF-beta inhibitory signalin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202118

    authors: Villanueva A,García C,Paules AB,Vicente M,Megías M,Reyes G,de Villalonga P,Agell N,Lluís F,Bachs O,Capellá G

    更新日期:1998-10-15 00:00:00

  • TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

    abstract::Tumor suppressor p53 has been shown to repress expression of vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen and a key mediator of tumor angiogenesis. The p63 gene, recently identified as a p53-relative, encodes multiple isoforms with structural and functional similarities and differenc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205330

    authors: Senoo M,Matsumura Y,Habu S

    更新日期:2002-04-11 00:00:00

  • The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis.

    abstract::Expression of viral proteins may result in susceptibility of cells to the cytotoxic effect of Tumor Necrosis Factor Alpha (TNF). While murine C127 cells containing the bovine papillomavirus type 1 (BPV-1) genome were reported to exhibit increased TNF sensitivity, the gene(s) responsible was not identified. The BPV-1 E...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202373

    authors: Rapp L,Liu Y,Hong Y,Androphy EJ,Chen JJ

    更新日期:1999-01-21 00:00:00

  • Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1.

    abstract::We tested the cytotoxic action of 8-hydroxyguanine (8ohG) by observing the viability of several leukemic cell lines (KG-1, U937, Jurkat and K 562) in the presence of 8-hydroxydeoxyguanosine (8ohdG), a nucleoside of 8ohG. It was found that 8ohdG showed cytotoxic action only to KG-1 and that only KG-1 showed a homozygou...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203787

    authors: Hyun JW,Choi JY,Zeng HH,Lee YS,Kim HS,Yoon SH,Chung MH

    更新日期:2000-09-14 00:00:00

  • Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy.

    abstract::Loss of RASSF1A leads to several mitotic abnormalities, including cytokinesis failure and tetraploidization. Uncontrolled proliferation of tetraploid cells is known to trigger genomic instability and tumor development and is normally prevented through activation of a p53-dependent tetraploidy checkpoint. RASSF1A is th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.440

    authors: Tommasi S,Besaratinia A,Wilczynski SP,Pfeifer GP

    更新日期:2011-02-10 00:00:00

  • The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

    abstract::The role of TGF-β signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive 'TGF-β paradox'. Herein, we identify a mechanism by which Six1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.11

    authors: Smith AL,Iwanaga R,Drasin DJ,Micalizzi DS,Vartuli RL,Tan AC,Ford HL

    更新日期:2012-12-13 00:00:00

  • BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase.

    abstract::The BRCA1-associated RING domain protein BARD1 acts with BRCA1 in double-strand break repair and ubiquitination. BARD1 plays a role as mediator of apoptosis by binding to and stabilizing p53, and BARD1-repressed cells are resistant to apoptosis. We therefore investigated the mechanism by which BARD1 induces p53 stabil...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208491

    authors: Feki A,Jefford CE,Berardi P,Wu JY,Cartier L,Krause KH,Irminger-Finger I

    更新日期:2005-05-26 00:00:00

  • TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis.

    abstract::Tumor cells, stromal cell compartment and the extracellular matrix (ECM) together generate a multifaceted tumor microenvironment. Matrix metalloproteinases and their tissue inhibitors (TIMPs) provide a means for tumor-stromal interaction during tumorigenesis. Among TIMPs, TIMP-3 is uniquely localized to the ECM and is...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209104

    authors: Cruz-Muñoz W,Kim I,Khokha R

    更新日期:2006-01-26 00:00:00

  • Dysregulation of growth factor signaling in human hepatocellular carcinoma.

    abstract::Dysregulation of pleiotropic growth factors, receptors and their downstream signaling pathway components represent a central protumorigenic principle in human hepatocarcinogenesis. Especially the Insulin-like Growth Factor/IGF-1 receptor (IGF/IGF-1R), Hepatocyte Growth Factor (HGF/MET), Wingless (Wnt/beta-catenin/FZD)...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1209556

    authors: Breuhahn K,Longerich T,Schirmacher P

    更新日期:2006-06-26 00:00:00

  • A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells.

    abstract::Increased cancer stem cell content during development of resistance to tamoxifen in breast cancer is driven by multiple signals, including Sox2-dependent activation of Wnt signalling. Here, we show that Sox2 increases and estrogen reduces the expression of the transcription factor Sox9. Gain and loss of function assay...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0656-7

    authors: Domenici G,Aurrekoetxea-Rodríguez I,Simões BM,Rábano M,Lee SY,Millán JS,Comaills V,Oliemuller E,López-Ruiz JA,Zabalza I,Howard BA,Kypta RM,Vivanco MD

    更新日期:2019-04-01 00:00:00

  • Cancer stem cell self-renewal as a therapeutic target in human oral cancer.

    abstract::Tumor recurrence following treatment remains a major clinical challenge in oral cavity cancer. Cancer stem cells (CSCs) have been isolated from human oral cancers and been considered as the driving force of tumor recurrence and metastasis. However, it still remains unclear whether targeting CSCs in oral cancer is a cl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0800-z

    authors: Hu J,Mirshahidi S,Simental A,Lee SC,De Andrade Filho PA,Peterson NR,Duerksen-Hughes P,Yuan X

    更新日期:2019-07-01 00:00:00

  • Cell type-specific responses of human cells to inhibition of replication licensing.

    abstract::Replication origins are 'licensed' for a single initiation event by loading Mcm2-7 complexes during late mitosis and G1. Licensing is blocked at other cell cycle stages by the activity of cyclin-dependent kinases and a small protein called geminin. Here, we describe the effects of over-expressing a non-degradable form...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205910

    authors: Shreeram S,Sparks A,Lane DP,Blow JJ

    更新日期:2002-09-26 00:00:00

  • Different functions are required for initiation and maintenance of immortalization of rat embryo fibroblasts by SV40 large T antigen.

    abstract::We have used two different, but complementary assays to characterize functions of SV40 T antigen that are necessary for its ability to immortalize rat embryo fibroblasts. In accordance with previous work, we found that several functions were required. These include activities that map to the p53 binding domain and the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203154

    authors: Powell AJ,Darmon AJ,Gonos ES,Lam EW,Peden KW,Jat PS

    更新日期:1999-12-02 00:00:00

  • Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

    abstract::RAS is a small GTP binding protein mutated in approximately 30% human cancer. Despite its important role in the initiation and progression of human cancer, the underlying mechanism of RAS-induced human epithelial transformation remains elusive. In this study, we probe the cellular and molecular mechanisms of RAS-media...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208753

    authors: Young T,Mei F,Liu J,Bast RC Jr,Kurosky A,Cheng X

    更新日期:2005-09-08 00:00:00

  • Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP.

    abstract::YAP (Yes-associated protein) oncogene has been found to form a stable complex with members of the Angiomotin (Amot) family of proteins, which bind WW domains of YAP and sequester the protein in the cytoplasm and junctional complexes. The Amot-mediated retention of YAP in the cytoplasm results in the inhibition of its ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.216

    authors: Oka T,Schmitt AP,Sudol M

    更新日期:2012-01-05 00:00:00

  • A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing: a founder mutation in the Chinese population.

    abstract::We have previously reported that there is a high incidence of microsatellite instability (MSI) and germline mismatch repair gene mutation in colorectal cancer arising from young Hong Kong Chinese. Most of the germline mutations involve hMSH2, which is different from the mutation spectrum in the Western population. It ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204376

    authors: Chan TL,Yuen ST,Ho JW,Chan AS,Kwan K,Chung LP,Lam PW,Tse CW,Leung SY

    更新日期:2001-05-24 00:00:00

  • The MEK-1/ERKs signalling pathway is differentially involved in the self-renewal of early and late avian erythroid progenitor cells.

    abstract::Making decisions between self-renewal and differentiation is a central ability of stem cells. Elucidation of molecular networks governing this decision is therefore of prime importance. A model of choice to explore this question is represented by chicken erythroid progenitors, in which self-renewal versus differentiat...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207049

    authors: Dazy S,Damiola F,Parisey N,Beug H,Gandrillon O

    更新日期:2003-12-18 00:00:00

  • p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.

    abstract::The effect of p53-dependent cell-cycle arrest and senescence on Emu-myc-induced B-cell lymphoma development remains controversial. To address this question, we crossed Emu-myc mice with the p53(515C) mutant mouse, encoding the mutant p53R172P protein that retains the ability to activate the cell-cycle inhibitor and se...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.423

    authors: Post SM,Quintás-Cardama A,Terzian T,Smith C,Eischen CM,Lozano G

    更新日期:2010-03-04 00:00:00

  • HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.

    abstract::Amplified segments of the long arm of chromosome 12 are frequently observed in human sarcomas. In most cases there are separate amplified regions around the MDM2 and CDK4 genes. Here we show recurrent amplification of a third region encompassing HMGIC, a human architectural transcription factor gene. Reduced amplifica...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201135

    authors: Berner JM,Meza-Zepeda LA,Kools PF,Forus A,Schoenmakers EF,Van de Ven WJ,Fodstad O,Myklebost O

    更新日期:1997-06-19 00:00:00

  • Overexpression of p21waf1/cip1 arrests the growth of chicken embryo fibroblasts that overexpress E2F1.

    abstract::P21waf1/cip1 is a potent inhibitor of cell cycle progression and can inhibit the growth of both normal cells and cells transformed by a number of oncogenes. However, the ability of p21waf1/cip1 to inhibit the growth of cells that overexpress the transcriptional transactivator E2F1 is controversial: it has been reporte...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201849

    authors: Givol I,Givol D,Hughes SH

    更新日期:1998-06-18 00:00:00

  • Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.

    abstract::The mechanisms by which the p53 tumour suppressor protein would, in vivo, co-ordinate the adaptive response to genotoxic stress is poorly understood. p53 has been shown to transactivate several genes that could be involved in two main cellular responses, growth arrest and apoptosis. To get further insight into the tis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203366

    authors: Bouvard V,Zaitchouk T,Vacher M,Duthu A,Canivet M,Choisy-Rossi C,Nieruchalski M,May E

    更新日期:2000-02-03 00:00:00

  • Identification of novel VHL targets that are associated with the development of renal cell carcinoma.

    abstract::von Hippel-Lindau (VHL) disease is a dominantly inherited family cancer syndrome characterized by the development of retinal and central nervous system haemangioblastomas, renal cell carcinoma (RCC) and phaeochromocytoma. Specific germline VHL mutations may predispose to haemangioblastomas, RCC and phaeochromocytoma t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209932

    authors: Abdulrahman M,Maina EN,Morris MR,Zatyka M,Raval RR,Banks RE,Wiesener MS,Richards FM,Johnson CM,Latif F,Maher ER

    更新日期:2007-03-08 00:00:00

  • Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.

    abstract::Acquired therapeutic resistance is the major drawback to effective systemic therapies for cancers. Aggressive triple-negative breast cancers (TNBC) develop resistance to chemotherapies rapidly, whereas the underlying mechanisms are not completely understood. Here we show that genotoxic treatments significantly increas...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.189

    authors: Niu J,Xue A,Chi Y,Xue J,Wang W,Zhao Z,Fan M,Yang CH,Shao ZM,Pfeffer LM,Wu J,Wu ZH

    更新日期:2016-03-10 00:00:00

  • Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.

    abstract::Cyclooxygenase-2 (COX-2) is involved in diverse processes such as inflammation, carcinogenesis and apoptosis. As COX-2 inhibitors interfere with these processes, inhibition of COX-2 has been suggested as a promising anticancer treatment. However, the role of COX-2 in modulation of apoptosis as well as the death pathwa...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206837

    authors: Totzke G,Schulze-Osthoff K,Jänicke RU

    更新日期:2003-09-11 00:00:00

  • aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia.

    abstract::Atypical protein kinase C (aPKC) and Lethal giant larvae (Lgl) regulate apical-basal polarity in Drosophila and mammalian epithelia. At the apical domain, aPKC phosphorylates and displaces Lgl that, in turn, maintains aPKC inactive at the basolateral region. The mutual exclusion of these two proteins seems to be cruci...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210389

    authors: Grifoni D,Garoia F,Bellosta P,Parisi F,De Biase D,Collina G,Strand D,Cavicchi S,Pession A

    更新日期:2007-08-30 00:00:00

  • Characterization of distinct consecutive phases in non-genotoxic p53-induced apoptosis of Ewing tumor cells and the rate-limiting role of caspase 8.

    abstract::To dissect the p53-dependent apoptotic pathway, events following induction of temperature sensitive (ts) p53val138 were studied in a Ewing tumor cell line. Transcriptional deregulation of p53 targets first observable after 1 h at 32 degrees C preceded activation of caspases and the break-down of mitochondrial respirat...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203780

    authors: Kovar H,Jug G,Printz D,Bartl S,Schmid G,Wesierska-Gadek J

    更新日期:2000-08-24 00:00:00

  • A critical role for choline kinase-alpha in the aggressiveness of bladder carcinomas.

    abstract::Bladder cancer is one of the most common causes of death in industrialized countries. New tumor markers and therapeutic approaches are still needed to improve the management of bladder cancer patients. Choline kinase-alpha (ChoKalpha) is a metabolic enzyme that has a role in cell proliferation and transformation. Inhi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.91

    authors: Hernando E,Sarmentero-Estrada J,Koppie T,Belda-Iniesta C,Ramírez de Molina V,Cejas P,Ozu C,Le C,Sánchez JJ,González-Barón M,Koutcher J,Cordón-Cardó C,Bochner BH,Lacal JC,Ramírez de Molina A

    更新日期:2009-07-02 00:00:00

  • MAGI-3 is involved in the regulation of the JNK signaling pathway as a scaffold protein for frizzled and Ltap.

    abstract::A seven-transmembrane protein, frizzled, has been implicated in a planar cell polarity (PCP) pathway as well as the canonical Wnt signaling pathway. Although both pathways require a cytoplasmic protein, dishevelled, the molecular mechanism by which frizzled regulates intracellular signaling remains to be elucidated. I...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207817

    authors: Yao R,Natsume Y,Noda T

    更新日期:2004-08-12 00:00:00

  • Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.

    abstract::The ability of glioma cells to migrate great distances from a primary tumor mass is the primary cause of tumor recurrence. The urokinase-type plasminogen activator (uPA) is a serine protease that can initiate proteolytic cascades, which result in remodeling of extracellular matrix and basement membrane, allowing cells...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206164

    authors: Chandrasekar N,Mohanam S,Gujrati M,Olivero WC,Dinh DH,Rao JS

    更新日期:2003-01-23 00:00:00

  • Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.

    abstract::The RAF-mitogen-activated protein kinase kinase 1/2-extracellular signal-regulated kinase 1/2 (RAF-MEK1/2-ERK1/2) pathway is activated in many human tumours and can protect cells against growth factor deprivation; however, most such studies have relied upon overexpression of RAF or MEK constructs that are not found in...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.335

    authors: Wickenden JA,Jin H,Johnson M,Gillings AS,Newson C,Austin M,Chell SD,Balmanno K,Pritchard CA,Cook SJ

    更新日期:2008-12-04 00:00:00